Blood transfusion after percutaneous coronary intervention and risk of subsequent adverse outcomes: A systematic review and meta-analysis

JACC: Cardiovascular Interventions

Volumn 8, Issue 3, 2015, Pages 436-446

  Kwok, Chun Shing ^a   Sherwood, Matthew W ^b   Watson, Sarah M ^c   Nasir, Samina B ^c   Sperrin, Matt ^d   Nolan, Jim ^e   Kinnaird, Tim ^f   Kiatchoosakun, Songsak ^g   Ludman, Peter F ^h   De Belder, Mark A ⁱ   Rao, Sunil V ^b   Mamas, Mamas A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c ROYAL BOLTON HOSPITAL   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^f UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^g KHON KAEN UNIVERSITY   (Thailand)

^h QUEEN ELIZABETH HOSPITAL   (United Kingdom)

ⁱ JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

blood transfusion; cardiovascular events; meta analysis; mortality

Indexed keywords

HEMOGLOBIN; ANTICOAGULANT AGENT;

ADVERSE OUTCOME; AGE DISTRIBUTION; ANEMIA; BLOOD TRANSFUSION; CARDIOVASCULAR MORTALITY; CASE CONTROL STUDY; COHORT ANALYSIS; COMORBIDITY; CRYOPRECIPITATE; ERYTHROCYTE TRANSFUSION; HEART DISEASE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; META ANALYSIS; MULTICENTER STUDY (TOPIC); PERCUTANEOUS CORONARY INTERVENTION; PLASMA TRANSFUSION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PUBLISHING; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; REVIEW; SEX DIFFERENCE; SYSTEMATIC REVIEW; THROMBOCYTE TRANSFUSION; ADVERSE EFFECTS; CHEMICALLY INDUCED; CHI SQUARE DISTRIBUTION; HEART DISEASES; HEMORRHAGE; MORTALITY; ODDS RATIO; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ANEMIA; ANTICOAGULANTS; BLOOD TRANSFUSION; CHI-SQUARE DISTRIBUTION; HEART DISEASES; HEMORRHAGE; HUMANS; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84926421517     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2014.09.026     Document Type: Article

References (43)

1. C.S. Kwok, S.V. Rao, and P.K. Myint Major bleeding after percutaneous coronary intervention and risk of subsequent mortality: a systematic review and meta-analysis Open Heart 1 2014 e000021
2. A.J. Chase, E.B. Fretz, and W.P. Warburton Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg) Heart 94 2008 1019 1025
3. S.S. Jolly, S. Yusuf, J. Cairns for the RIVAL Trial Group Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial Lancet 377 2011 1409 1420
4. R. Mehran, A.J. Lansky, B. Witzenbichler for the HORIZONS-AMI Trial Investigators Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial Lancet 374 2009 1149 1159
5. M.W. Sherwood, Y. Wang, J.P. Curtis, E.D. Peterson, and S.V. Rao Patterns and outcomes of red blood cell transfusion in patients undergoing percutaneous coronary intervention JAMA 311 2014 836 843
6. X. Yang, K.P. Alexander, A.Y. Chen for the CRUSADE Investigators The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative J Am Coll Cardiol 46 2005 1490 1495
7. T. Pilgrim, F. Vetterli, and B. Kalesan The impact of anemia on long-term clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stents Circ Cardiovasc Interv 5 2012 202 210
8. M.S. Sabatine, D.A. Morrow, and R.P. Giugliano Association of hemoglobin levels with clinical outcomes in acute coronary syndromes Circulation 111 2005 2042 2049
9. J.L. Carson, B.J. Grossman, and S. Kleinman Red blood cell transfusion: a clinical practice guideline from the AABB∗ Ann Intern Med 157 2012 49 58
10. M. Moscucci, M. Ricciardi, and K.A. Eagle Frequency, predictors, and appropriateness of blood transfusion after percutaneous coronary interventions Am J Cardiol 81 1998 702 707
11. S. Chatterjee, J. Wetterslev, A. Sharma, E. Lichstein, and D. Mukherjee Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysis JAMA Intern Med 173 2013 132 139
12. J.P. Ioannidis, and T.A. Trikalinos The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey CMAJ 176 2007 1091 1096
13. H.T. Davies, I.K. Crombie, and M. Tavakoli When can odds ratios mislead? BMJ 316 1998 989 991
14. J.J. Brugts, N. Mercado, and S. Hu Relation of periprocedural bleeding complications and long-term outcome in patients undergoing percutaneous coronary revascularization (from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] Trial) Am J Cardiol 103 2009 917 922
15. J. Byrne, M.S. Spence, and E. Fretz Body mass index, periprocedural bleeding, and outcome following percutaneous coronary intervention (from the British Columbia Cardiac Registry) Am J Cardiol 103 2009 507 511
16. N. Cosgrove, J. Kostis, A. Moreyra, T. Vagaonescu, and A. Wilson Transfusions after percutaneous coronary intervention for ST-T segment elevation acute myocardial infarction patients are associated with increased long term mortality: a statewide registry study Catheter Cardiovasc Interv 73 2009 S14
17. M.R. Dada, M. Gill, and S. Samee Impact of anemia, bleeding and transfusion on percutaneous coronary intervention outcomes J Am Coll Cardiol 53 2009 A379
18. B.J. Doyle, H.H. Ting, and M.R. Bell Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005 J Am Coll Cardiol Intv 1 2008 202 209
19. M. Ergelen, H. Uyarel, and S. Altay Prognostic impact of red blood cell transfusion in patients undergoing primary angioplasty for ST elevation myocardial infarction Coron Artery Dis 23 2012 517 522
20. S.M. Jani, D.E. Smith, and D. Share Blood transfusion and in-hospital outcomes in anemic patients with myocardial infarction undergoing percutaneous coronary intervention Clin Cardiol 30 2007 II49 II56
21. E.M. Jolicoeur, W.W. O'Neill, and A. Hellkamp Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention Eur Heart J 30 2009 2575 2583
22. P. Kim, S. Dixon, A.B. Eisenbrey, B. O'Malley, J. Boura, and W. O'Neill Impact of acute blood loss anemia and red blood cell transfusion on mortality after percutaneous coronary intervention Clin Cardiol 30 Suppl 2 2007 II35 II43
23. T.D. Kinnaird, E. Stabile, and G.S. Mintz Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions Am J Cardiol 92 2003 930 935
24. C.C. Leung, S.A. Sabir, and J.R. Brown The impact of hematocrit drop on long-term survival after cardiac catheterization: insights from the Dartmouth Dynamic Registry Catheter Cardiovasc Interv 75 2010 378 386
25. G. Maluenda, G. Lemesle, and A. Syed Does transfusion for major bleeding after percutaneous coronary intervention impact clinical outcome in patients admitted with normal Hematocrit? J Am Coll Cardiol 53 2009 A72
26. E. Nikolsky, R. Mehran, and H.M. Sadeghi Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial J Am Coll Cardiol Intv 2 2009 624 632
27. S.D. Robinson, C. Janssen, and E.B. Fretz Red blood cell storage duration and mortality in patients undergoing percutaneous coronary intervention Am Heart J 159 2010 876 881
28. S.D. Robinson, C. Janssen, and E.B. Fretz Non-red blood cell transfusion as a risk factor for mortality following percutaneous coronary intervention Int J Cardiol 157 2012 169 173
29. M. Tajstra, M. Gasior, and M. Gierlotka Comparison between five-year mortality of patients with and without red blood cell transfusion after percutaneous coronary intervention for ST-elevation acute myocardial infarction Kardiol Pol 71 2013 1029 1035
30. R. Valenti, G. Moschi, and R. Vergara Relationship of blood transfusion and clinical outcome in patients treated with primary angioplasty for acute myocardial infarction J Am Coll Cardiol 56 2010 B13
31. P.C. Hebert, G. Wells, and C. Martin Variation in red cell transfusion practice in the intensive care unit: a multicentre cohort study Crit Care 3 1999 57 63
32. L.T. Goodnough, J.H. Levy, and M.F. Murphy Concepts of blood transfusion in adults Lancet 381 2013 1845 1854
33. M.D. Voeltz, A.D. Patel, F. Feit, R. Fazel, A.M. Lincoff, and S.V. Manoukian Effect of anemia on hemorrhagic complications and mortality following percutaneous coronary intervention Am J Cardiol 99 2007 1513 1517
34. E. Nikolsky, R. Mehran, and E.D. Aymong Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions Am J Cardiol 94 2004 1023 1027
35. Y. Kitai, N. Ozasa, T. Morimoto for the CREDO-Kyoto Registry Investigators Prognostic implications of anemia with or without chronic kidney disease in patients undergoing elective percutaneous coronary intervention Int J Cardiol 168 2013 5221 5228
36. J.L. Carson, M.M. Brooks, and J.D. Abbott Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease Am Heart J 165 2013 964 971.e1
37. B.J. Doyle, C.S. Rihal, D.A. Gastineau, and D.R. Holmes Jr. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice J Am Coll Cardiol 53 2009 2019 2027
38. J. Silvain, J. Abtan, and M. Kerneis Impact of red blood cell transfusion on platelet aggregation and inflammatory response in anemic coronary and noncoronary patients: the TRANSFUSION-2 study (Impact of Transfusion of Red Blood Cell on Platelet Activation and Aggregation Studied With Flow Cytometry Use and Light Transmission Aggregometry) J Am Coll Cardiol 63 2014 1289 1296
39. M. Hedstrom, P.A. Flordal, T. Ahl, J. Svensson, and N. Dalen Autologous blood transfusion in hip replacement: no effect on blood loss but less increase of plasminogen activator inhibitor in a randomized series of 80 patients Acta Orthop Scand 67 1996 317 320
40. H.G. Welch, K.R. Meehan, and L.T. Goodnough Prudent strategies for elective red blood cell transfusion Ann Intern Med 116 1992 393 402
41. J.D. Reynolds, G.S. Ahearn, M. Angelo, J. Zhang, F. Cobb, and J.S. Stamler S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood Proc Natl Acad Sci U S A 104 2007 17058 17062
42. G.W. Stone, B. Witzenbichler, G. Guagliumi for the HORIZONS-AMI Trial Investigators Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230
43. M.A. Mamas, K. Ratib, and H. Routledge Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice? J Am Coll Cardiol Intv 6 2013 698 706